Complex Regional Pain Syndrome

5

Review clinical trials related to Complex Regional Pain Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

How the Brain and Body Recover After a Wrist Fracture

What is the problem? A wrist fracture is a common injury, affecting about 100,000 people in the UK each year. While most people recover well, a significant minority, between 10% and 20%, develop persistent pain and disability that lasts long after the bone has healed. In some cases this leads to a severe chronic pain condition called Complex Regional Pain Syndrome (CRPS). Currently we cannot easily predict who will recover and who may not, making it challenging to provide early targeted support. What are we trying to find out? We want to see if we can identify "signs" in the body, such as genetic markers, chemical messengers in the blood, and heart rate rhythms, that predict a person's recovery. We are also investigating the brain's "internal map" of the body. After an injury, this map can sometimes become "blurred" or less precise, which we believe is linked to ongoing pain. Our goal is to use this information to help in identify patients at high risk of chronic pain so they could receive better treatment in the future. What will happen in the study? We are inviting 250 participants: 200 people with a recent wrist fracture and 50 people who already live with long-term CRPS to act as a comparison group. All participants will first take part in a baseline assessment. This involves completing questionnaires (including a 0-10 pain rating scale), providing a blood sample, and taking part in simple bedside tests. These tests will also measure your internal body map by checking how accurately you can identify finger touches with your eyes closed and how you compare the size or weight of your limbs. Based on the results of these objective tests, we will invite some participants with recent wrist fractures to take part in specific sub-studies: * Brain Scans (24 people): If the bedside tests show changes in your internal map, we will invite you for two fMRI scans, six months apart, to watch the internal map in action whilst performing simple hand tasks. * Fitness Watches (50 people): Based on your pain rating scores, we will invite 25 people with higher pain and 25 people with lower pain to wear a watch for five days, at the beginning and end of their recovery, to track heart rate rhythms. * Virtual Reality (20 people): If you still have ongoing pain or a blurred internal map at 6 months, we may invite you to test at-home VR equipment to see if it helps re-train the brain. Who are we? Our research team includes experts in genetics, brain imaging, pain, and modern digital technologies who have experience in delivering clinical trials. How will we tell people what we found out? We are committed to sharing what we learn with the people who make our research possible. We will therefore inform participants and public. Once the study is complete, we will: * Publish a plain English summary of the results to the public registry ClinicalTrials.gov within 12 months of the study ending * Provide a direct update to participants who have consented to be contacted for future research via email * Offer community sharing of our findings through our sponsor Cambridge Arthritis Research Endeavour (CARE) website * Publish in Academic literature the full scientific results in medical journals to ensure that other doctors and researchers can learn from this study

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cambridge University Hospitals NHS Foundation TrustUpdated: Aug 20, 2026Locations: 1
Eligibility criteria

Not listed

Status: Not yet recruiting

Hyperbaric Oxygen Therapy in Complex Regional Pain Syndrome

The aim of the study is to investigate the efficacy of hyperbaric oxygen therapy as an adjunct in the management of severe complex regional pain syndrome.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital OstravaUpdated: Mar 3, 2026Locations: 2
Eligibility criteria

HBOT contraindications (pregnancy; use of bleomycin, cisplatin, disulfiram, and... [+1]

Status: Recruiting

Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

The investigators are testing treatment with low-dose naltrexone (LDN) for symptom relief of complex regional pain syndrome (CRPS). Study participants will be randomly assigned to receive either LDN or placebo for a period of several weeks. During this period participants will be asked to attend either in-person or virtual study visits and complete questionnaires.

Participants needed: 120
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Stanford UniversityUpdated: May 29, 2025Locations: 1
Eligibility criteria

Upper and/or lower extremity CRPS [+3]

Any known allergy to naltrexone or naloxone [+2]

Status: Recruiting

The Effects of Whirlpool and Contrast Bath in Patients with Complex Regional Pain Syndrome After Distal Radius Fracture

The aim of our study is to investigate the effects of whirlpool bath and contrast bath treatments on pain, disability, functionality and grip strength in patients with complex regional pain syndrome after distal radius fracture.

Participants needed: 40
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Afyonkarahisar Health Sciences UniversityUpdated: Jan 30, 2025Locations: 1
Eligibility criteria

Patients with complex regional pain syndrome type-1 (CRPS-type 1) after distal r...

Orthopedic injuries (other accompanying orthopedic fractures, such as ulna fract... [+9]

Status: Recruiting

The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

The aim of this trial is to determine the potential effects and mechanisms of cannabinoid-induced pain relief in complex regional pain syndrome (CRPS). Multiple psychophysical approaches will be conducted in conjunction with psychological and inflammatory marker testing to determine if and how cannabinoids produce stabilized improvement in CRPS-related pain and comorbidities. The trial consisted of a pre-treatment screening period, six-week treatment period and a two-week follow-up.

Participants needed: 52
Trial details
Phase: Phase 1Age: 21-75Biological sex: AllType: InterventionalSponsor: University of California, San DiegoUpdated: Jun 7, 2024Locations: 2
Eligibility criteria

Provision of signed and dated informed consent form. [+8]

Fail cannabis screening [+9]